Patent details

EP3328425 Title: COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMENT OF CANCER

Basic Information

Publication number:
EP3328425
PCT Application Number:
IB2016054487
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167504950
PCT Publication Number:
WO2017017623
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMENT OF CANCER
French Title of Invention:
UTILISATION COMBINEE DEES ANTICOPRS ANTI PD-1 ET ANTI M-CSF DANS LE TRAITMENT DE CANCERS
German Title of Invention:
GEMEINSAME VERWENDUNG VON ANTI PD-1 UND ANTI M-CSF-ANTIKÖRPER IN DER BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
27/07/2016
Grant date:
25/08/2021
EP Publication Date:
06/06/2018
PCT Publication Date:
02/02/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/08/2021
EP B1 Publication Date:
25/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/07/2022
Expiration date:
27/07/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/08/2021
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
MACISAAC, Kenzie
Address:
United States (US)

2

Name:
FJAELLSKOG, Marie-Louise
Address:
United States (US)

3

Name:
CIPOLLETTA, Daniela
Address:
United States (US)

4

Name:
CAO, Zhu
Address:
United States (US)

5

Name:
CAMERON, John
Address:
United States (US)

Priority

1

Priority Number:
201562198384 P
Priority Date:
29/07/2015
Priority Country:
United States (US)

2

Priority Number:
201662352637 P
Priority Date:
21/06/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61P 35/00; C07K 16/24; A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202134
Publication date:
25/08/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages